KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xylem (XYL) Total Liabilities (2016 - 2025)

Xylem has reported Total Liabilities over the past 16 years, most recently at $5.9 billion for Q4 2025.

  • Quarterly results put Total Liabilities at $5.9 billion for Q4 2025, up 4.88% from a year ago — trailing twelve months through Dec 2025 was $5.9 billion (up 4.88% YoY), and the annual figure for FY2025 was $5.9 billion, up 4.88%.
  • Total Liabilities for Q4 2025 was $5.9 billion at Xylem, up from $5.9 billion in the prior quarter.
  • Over the last five years, Total Liabilities for XYL hit a ceiling of $6.2 billion in Q2 2023 and a floor of $4.4 billion in Q1 2023.
  • Median Total Liabilities over the past 5 years was $5.6 billion (2021), compared with a mean of $5.4 billion.
  • Peak annual rise in Total Liabilities hit 33.42% in 2023, while the deepest fall reached 13.21% in 2023.
  • Xylem's Total Liabilities stood at $5.1 billion in 2021, then dropped by 11.9% to $4.4 billion in 2022, then surged by 33.42% to $5.9 billion in 2023, then dropped by 5.48% to $5.6 billion in 2024, then grew by 4.88% to $5.9 billion in 2025.
  • The last three reported values for Total Liabilities were $5.9 billion (Q4 2025), $5.9 billion (Q3 2025), and $5.9 billion (Q2 2025) per Business Quant data.